652-67-5
Chemical Structure
Isosorbide
Synonym(s): D-Isosorbide; Dianhydro-D-glucitol
- CAS No.: 652-67-5
- Formula:C6H10O4
- Molecular Weight:146.14
IUPAC Name: (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol
InChIKey: KLDXJTOLSGUMSJ-JGWLITMVSA-N
SMILES: O[C@H]1[C@]2([H])[C@]([C@@H](O)CO2)([H])OC1
Biological Activity: Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Isosorbide | 98.76% | Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isosorbide (Standard) | ≥98% | Isosorbide (Standard) is the analytical standard of Isosorbide. This product is intended for research and analytical applications. Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isosorbide-d8 | Isosorbide-d8 is the deuterium labeled Isosorbide (HY-B1469). Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Rose M, et, al. Isosorbide as a renewable platform chemical for versatile applications--quo vadis? ChemSusChem. 2012 Jan 9;5(1):167-76. [Content Brief]
- [2]. Nozawa I, et, al. Efficacy of long-term administration of isosorbide for Ménière's disease. ORL J Otorhinolaryngol Relat Spec. May-Jun 1995;57(3):135-40. [Content Brief]